Vivos Therapeutics, Inc.VVOSNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor VVOS?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor VVOS

Key Statistics

About

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA.

Sector

Manufacturing

Industry

Surgical and Medical Instrument Manufacturing

www.vivoslife.com →

News

RTX to invest $139 million in Singapore, signing multiple MOUs with Economic Development Board

prnewswire.com

Lamb Weston: Turnaround Opportunity As Fast-Food Headwinds Mask Improving Fundamentals

seekingalpha.com

Berkshire Hathaway: I'm More Bullish Than Ever

seekingalpha.com

Halozyme Therapeutics: Key Acquisitions To Help Drive Long-Term Growth

seekingalpha.com

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRNS

newsfilecorp.com

Gold Hunter Resources Closes Final Tranche of Financing; Fully Funded for Inaugural Drilling Program

newsfilecorp.com

Oil Prices Slide as U.S.–Iran Talks Ease Geopolitical Risk and Remove Fear Premium

fxempire.com

GRX: Underwhelming Performance Metrics And Inconsistent Dividend Coverage

seekingalpha.com

SoftBank subsidiary to work with Intel on next-gen memory for AI

cnbc.com

The Top 5 Stocks to Double Up on Right Now

fool.com

VB: Bottom-Up And Top-Down Analysis Points To Further Outperformance

seekingalpha.com

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

prnewswire.com

Better Dividend Stock: Energy Transfer vs. Enterprise Products Partners in 2026

fool.com

Gold and silver rebound after historic wipeout as analysts say thematic drivers stay intact

cnbc.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

RTX to invest $139 million in Singapore, signing multiple MOUs with Economic Development Board

Lamb Weston: Turnaround Opportunity As Fast-Food Headwinds Mask Improving Fundamentals

Berkshire Hathaway: I'm More Bullish Than Ever

Halozyme Therapeutics: Key Acquisitions To Help Drive Long-Term Growth

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRNS

My Top 3 Predictions for Nvidia in 2026

Deckers Outdoor: The Reasons Why I Upgrade From Hold To Buy

Hitachi: Buy Reiterated On This Potential SaaS Opportunity

2 Warren Buffett Stocks to Buy Hand Over Fist in February

How Lemonade Stock Gained 22% Last Month

Why AppLovin Stock Lost 30% in January

Gold Hunter Resources Closes Final Tranche of Financing; Fully Funded for Inaugural Drilling Program

Oil Prices Slide as U.S.–Iran Talks Ease Geopolitical Risk and Remove Fear Premium

GRX: Underwhelming Performance Metrics And Inconsistent Dividend Coverage

SoftBank subsidiary to work with Intel on next-gen memory for AI

The Top 5 Stocks to Double Up on Right Now

VB: Bottom-Up And Top-Down Analysis Points To Further Outperformance

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

Better Dividend Stock: Energy Transfer vs. Enterprise Products Partners in 2026

Gold and silver rebound after historic wipeout as analysts say thematic drivers stay intact

Explore More

RTX to invest $139 million in Singapore, signing multiple MOUs with Economic Development Board

Lamb Weston: Turnaround Opportunity As Fast-Food Headwinds Mask Improving Fundamentals

Berkshire Hathaway: I'm More Bullish Than Ever

Halozyme Therapeutics: Key Acquisitions To Help Drive Long-Term Growth

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRNS

My Top 3 Predictions for Nvidia in 2026

Deckers Outdoor: The Reasons Why I Upgrade From Hold To Buy

Hitachi: Buy Reiterated On This Potential SaaS Opportunity

2 Warren Buffett Stocks to Buy Hand Over Fist in February

How Lemonade Stock Gained 22% Last Month

Why AppLovin Stock Lost 30% in January

Gold Hunter Resources Closes Final Tranche of Financing; Fully Funded for Inaugural Drilling Program

Oil Prices Slide as U.S.–Iran Talks Ease Geopolitical Risk and Remove Fear Premium

GRX: Underwhelming Performance Metrics And Inconsistent Dividend Coverage

SoftBank subsidiary to work with Intel on next-gen memory for AI

The Top 5 Stocks to Double Up on Right Now

VB: Bottom-Up And Top-Down Analysis Points To Further Outperformance

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

Better Dividend Stock: Energy Transfer vs. Enterprise Products Partners in 2026

Gold and silver rebound after historic wipeout as analysts say thematic drivers stay intact

Key Statistics